With this study, we introduce a liquid flush for catheters and other tubing-based applications that consists of a solution of bphenylethylamine (PEA) in tryptic soy broth. The initial experiments in multiwell polystyrene plates were conducted with Escherichia coli K-12 to assess the effectiveness of PEA at reducing planktonic growth, as well as the biomass and adenosine triphosphate (ATP) content of biofilm; PEA reduced these growth parameters as a function of increasing concentration. This effect was also seen in mutants of PEA catabolism, which leads us to believe that the PEA effect is due to PEA itself and not one of its degradation products. Since PEA reduced planktonic growth and biofilm when added at the time of inoculation, as well as at later time points, we propose PEA as a novel compound for the prevention and treatment of biofilm. PEA reduced planktonic growth and the ATP content of the biofilm for five bacterial pathogens, including an enterohemorrhagic E. coli, two uropathogenic E. coli, Pseudomonas aeruginosa and Staphylococcus aureus. A major finding of this study is the reduction of the ATP content of biofilm that formed in silicone tubing by periodic flushes of PEA. This experiment was performed to model antibiotic-lock treatment of an intravenous catheter. It was found that 10 mg ml À1 of PEA reduced the ATP content of biofilm of five bacterial strains by 96.3 % or more after 2 weeks of incubation and three treatments with PEA. For P. aeruginosa, the reduction in ATP content was paralleled by an identical percentage reduction in viable cells in the biofilm.
INTRODUCTION
Bacterial biofilm is defined as a sessile community of bacteria that can form on biotic or abiotic surfaces. Bacteria engulf themselves in extrapolymeric substances that keep them together and attached to the surface. Biofilm is estimated to contribute to 65 to 80 % of bacterial infections in humans. Examples of biofilm-associated infectious diseases include catheter-associated urinary tract infections [1] , periodontitis [2] and otitis [3] , as well as Pseudomonas aeruginosa infections of cystic fibrosis patients [4] . Among the hospitalacquired infections involving medical devices, intravascular catheters that are used for patients with chronic kidney failure [5] can lead to central line-associated bloodstream infections (CLABSI) [6] .
Among the multiple phenotypes that distinguish biofilmbound bacteria from planktonic ones is a greater resistance towards antibiotics. Even last-resort antibiotics are becoming insufficient due to overuse and methicillinand vancomycin-resistant Staphylococcus aureus [7] , as well as carbapenem-resistant Enterobacteriaceae [8] , are becoming more prevalent. Currently used technologies that are aimed at reducing medical device-associated biofilm infections include the incorporation of traditional antibiotics or novel antimicrobial substances into the device material [9, 10] . However, these materials are accompanied by high production costs and limited lifetimes, and they still cause the emergence of resistant bacterial strains [11] [12] [13] . An urgent need for novel approaches to inhibit biofilm is evident.
One approach that is currently being researched and is expected to yield novel treatments for biofilm-associated infections is to target bacterial gene regulatory and cell signalling pathways (for recent reviews, see [14, 15] ). The bacterial gene regulatory and cell signalling pathways that are investigated and discussed in this context include quorum sensing, which is used for cell-to-cell communication within the biofilm [16] , two-component systems that can contribute to quorum sensing [17] , cyclic D-GMP, which aids the transition from the motile to the sessile state [18] , and persister cells [19] .
Our own research may lead to the development of a different concept of biofilm prevention and treatment, with possible applications in the area of medical devices and food processing. We use bacterial nutrients in high concentrations to inhibit planktonic growth and biofilm. Among the 95 carbon and 95 nitrogen sources tested, b-phenylethylamine (PEA) and acetoacetate exhibited the most potent biofilm inhibiting effect on Escherichia coli O157 : H7 grown in liquid beef broth at 10 C and yielded the largest reduction in the viable cell counts recovered from small pieces of beef meat that had been inoculated with the bacteria [20] . In a follow-up study, acetoacetic acid and a chemically similar substance, ethyl acetoacetate, reduced the planktonic growth and biofilm amounts of Yersinia enterocolitica, Serratia marcescens and Enterobacter sakazakii [21] .
The research presented in this study builds upon the above concept and tests the effect of PEA supplied in the liquid bacterial growth medium on planktonic growth and several parameters of biofilm for one non-pathogenic E. coli K-12 strain and five clinically relevant bacterial pathogens. We were able to demonstrate a reduction in all growth and biofilm parameters tested when PEA was supplied at the time of inoculation and later during biofilm development. In a first step towards our goal of developing a novel biofilminhibiting catheter flush, we inoculated the silicone tubing of a haemodialysis fistula set and mimicked antibiotic-lock therapy (for a review, see [22] ) by leaving PEA solutions in the catheter to reduce the biofilm formed in the tubing. Three treatments with a solution of 10 mg ml À1 of PEA over a time period of 2 weeks reduced the adenosine triphosphate (ATP) concentration in the biofilm by more than 96 % for all bacterial strains tested and the viable cell counts for S. aureus and P. aeruginosa by 69.3 and 99.9 %, respectively.
METHODS

Bacterial strains
The bacterial strains used in this study are summarized in Table S1 (available in the online version of this article) and include one non-pathogenic E. coli K-12 strain with two isogenic mutants and five bacterial pathogens. The E. coli K-12 strain was AJW678, which was previously described as a good biofilm former [23] . The isogenic mutants were AJW678 DtynA750 :: kan (tynA, amine oxidase) and AJW678 DfeaB749 :: kan (feaB, phenylacetaldehyde dehydrogenase) mutants. The two mutations were obtained from the Keio collection (The Coli Genetic Stock Center, http:// cgsc2.biology.yale.edu/ [24] ) and moved into AJW678 by P1 transduction [25] . The bacterial pathogens include P. aeruginosa ATCC 15442 (A. Beloian), S. aureus ATCC 25923 (F. Schoenknecht), the enterohemolytic E. coli (EHEC) EDL932 [26] , and two uropathogenic E. coli (UPEC), UMN026 [27] and CFT073 [28] . The bacterial strains were maintained as freezer stocks at À80 C in 8 % dimethyl sulfoxide. Prior to each experiment, the E. coli strains were plated onto Luria-Bertani (LB; 10 g l À1 tryptone, 5 g l
À1
NaCl, 5 g l À1 yeast extract) agar plates. P. aeruginosa and S. aureus were plated onto tryptic soy agar (TSA; 15 g l À1 tryptone, 5 g l À1 soytone, 5 g l À1 NaCl, 15 g l À1 agar) plates. The plates were incubated overnight at 37 .
Formation of biofilm on 24 or 96 well polystyrene plates Liquid overnight cultures (10 ml) in tryptic soy broth (TSB; 17 g l À1 tryptone, 3 g l À1 soytone, 2.5 g l À1 glucose, 5 g l À1 NaCl, 2.5 g l À1 K 2 HPO 4 ) were centrifuged at 4500 g for 10 min and bacteria were resuspended in 10 ml of TSB. Individual wells of a 24-or 96-well polystyrene plate were inoculated with 1 ml (or 200 µl) of a TSB solution that contained between 0 and 50 mg ml À1 of PEA (TCI America, Portland, OR, USA) and bacteria at an optical density at 600 nm (OD 600 ) of approximately 0.05. The plates were incubated at 37 C for 16 or 24 h.
Performance of the growth and biofilm assays on polstyrene plates Planktonic growth was determined as end point growth by using a Synergy H1 Hybrid Reader (BioTek Instruments, Inc., Winooski, VT, USA), which recorded the OD 600 at the end of the incubation period. To characterize the biofilm at the end of the incubation period, two analyses were used; the crystal violet (CV) assay that stains live and dead biomass, as well as exopolysaccharide [29, 30] , and the ATP assay that measures the energy content of live bacteria [31] . Throughout this paper, we refer to planktonic growth as the result from the end point growth experiment, biofilm biomass as an outcome of the CV assay, and ATP content of the biofilm as a result of the ATP assay.
Prior to each assay, biofilm that had formed at the bottom of the 24 or 96 wells was rinsed three times with 1 ml (200 µl) of phosphate-buffered saline (PBS 
Formation of biofilm in silicone tubing
Liquid overnight cultures (10 ml) in TSB were centrifuged at 4500 g for 10 min and the bacteria were resuspended in TSB to an OD 600 of 0.05. An AV Fistula Needle 17 Ga. X 1-1/4 † Single Pk FW with MasterGuard anti-stick needle protector was purchased from Medisystems Corporation (Lawrence, MA, USA). The key piece of this haemodialysis fistula set is a 12-inch-long piece of silicone tubing with an inner diameter of 1/8 inch and an outer diameter of 3/8 inch (Fig. 1a) . Prior to inoculation with bacteria, the needle guard was pulled over the needle and cut off (Fig. 1b ). An alcohol swab was used to remove the cap at the other end of the tubing to be used later as a cap on the end of the tubing where the needle was removed. Using a sterile syringe, the tubing was inoculated with 3 ml of inocula (Fig. 1c) . The clamp on the tubing was then closed and the syringe was left attached to the tubing. Finally, the cap that was saved earlier was attached to the end of the tubing (Fig. 1d ).
Two pieces of tubing were inoculated for each bacterial strain, while an additional tubing was incubated with TSB only to serve as a negative control. The three tubings were incubated on an absorbant pad at 37 C. On the fourth day, the two tubings that were inoculated with the bacteria received either 3 ml of TSB or 3 ml of PEA treatment. In three separate experiments, the concentration of PEA in the treatment was either 100, 10, or 1 mg ml À1 in TSB. New sterile syringes were used, attached and left on the tubings each time. No new medium was pushed through the control tubing. The treatments were administered at days 4, 8 and 11. Incubation was continued until day 14.
Performance of the biofilm assays in silicone tubing At the end of the incubation, the biofilms were characterized with the CV and ATP assays. The tubings were flushed with 3 ml of PBS using a new sterile syringe. The syringe was detached and 3 ml of air was pushed through the tubing to flush out any liquid. Starting at the end that originally had the syringe attached, a 10 cm section of tubing was cut off with a sterile razor blade. From the 10 cm piece of tubing, six sections of about 1 mm were cut for the biofilm assays. Three of these smaller pieces of tubing were transferred to one microcentrifuge tube to be used for the CV assay. The other three sections of tubing were transferred into three separate microcentrifuge tubes, each filled with 1 ml of PBS to be used for the ATP assay and the determination of the viable cell counts. A new razor blade was used to cut each piece of tubing.
For the CV assay, 1.0 ml of 0.1 % CV in ddH 2 O was added to the microcentrifuge tube. The tube was incubated for 15 min. The silicone tubings were rinsed three times by being dipped into three separate and consecutive microcentrifuge tubes filled with 1 ml of ddH 2 O for 10 s using sterile forceps. The silicone tubings were then transferred into new individual microcentrifuge tubes, where they were allowed to dry at room temperature for at least 1 h. The CV was extracted by adding 500 µl of 80 % ethanol/20 % acetone to each microcentrifuge tube. The tubes were vortexed for 30 s and then incubated for 15 min. Then 0.15 ml of each extract was transferred into 1 well of a 96-well polystyrene plate and the OD 600 values were determined with the Synergy H1 Hybrid Reader.
For the ATP assay, the three microcentrifuge tubes that contained one section of silicone tubing and 1 ml of PBS were vortexed thoroughly for 1 min. Each individual tube was then vortexed for 10 s prior to transferring 100 ul to 1 well of a 96-well white plate. Then, 100 µl of BacTiter-Glo reagent was added to each well. The plates were covered with tinfoil, the solutions were thoroughly mixed and the plates were placed on a rotating shaker for 5 min. After this incubation, the luminescence was read using the Synergy H1 Hybrid Reader. The data are expressed as relative light units (RLU).
For the viable cell counts from the biofilms, 100 µl were obtained from the microcentrifuge tube that was used for the ATP assay, serially diluted in 1 : 10 steps and plated onto TSA plates. The plates were incubated for 24 h at 37 C. The viable cell counts were expressed as colony-forming units (c.f.u.) ml
À1
. The lower limit of detection for this assay was 999 c.f.u. ml À1 .
Data analysis
All assays were performed in six replicates, across which the averages and standard errors were calculated. For the plate assays, three biological replicates were produced on separate plates from independently grown overnight cultures. Each of the three plates contained two technical replicates from the same overnight culture. For the tube assays, two inoculated tubings per strain and PEA concentration constituted the biological replicates and the three slices per tubing the technical ones.
For the Fig. 2 data, statistical analysis was performed with an analysis of variance (ANOVA) that compared the means of the data across concentrations to determine whether any one of the concentrations yielded data that were statistically significant from the others (P-value below 0.05). Dunnett's adjustment for multiple comparisons was performed as a post hoc test to determine which of the concentrations yielded data that were different from those of the others. For the data in Figs 6 and 7, Student's t-test was used to determine the statistical significance of the difference between the mean data for each experimental condition and the mean data at the control condition (0 mg ml À1 of PEA). ) and ATP content of the biofilm (c) were determined after 16 h of growth at 37 C in TSB that contained increasing concentrations of PEA. The individual data points from the six replicates are indicated in black circles and the averages and standard errors are shown in red. The red asterisks above the data points indicate the PEA concentrations at which the planktonic growth, biofilm biomass, or ATP content of the biofilm showed a statistically significant difference from the data that were obtained at 0 mg ml À1 of PEA. The statistical significance of the differences was calculated with Dunnett's adjustment for multiple comparisons.
Differences were considered significant when the P-value was below 0.05. The results from the statistical analyses are included in Figs 2, 6 and 7 in red. The statistical analysis was performed with Statistical Analysis Software (SAS) version 8.4.
The PEA concentration that caused 50 % inhibition (IC 50 ) was determined for the data from Figs 4 and 5. The curve fitting was performed as a four-or five-parameter logistic using Master Plex Reader Fit analysis software (Hitachi Solutions America, Ltd, San Francisco, CA, USA) [32] . Coefficient of determination values (R 2 ) were indicated along with the IC 50 values. Percentage reductions were calculated as (aÀb)/a) Â 100, where a is the data (e.g. OD 600 , RLU) at the control condition (e.g. 0 mg ml À1 PEA) and b is the data at the experimental condition (e.g. specific concentration of PEA).
RESULTS
PEA reduced planktonic growth, biofilm biomass and the ATP content of the biofilm In a first experiment, the E. coli K-12 strain AJW678 was grown on 24-well polystyrene plates in TSB supplemented with a range of concentrations of PEA added to the liquid growth medium at the time of inoculation. Fig. 2a shows the planktonic growth measured as the OD 600 after 24 h of incubation at 37 C. The lowest PEA concentration that yielded an OD 600 different from that of the unsupplemented bacterial growth medium with statistical significance was 1 mg ml
À1
. A 50 % reduction in planktonic growth was achieved at approximately 3-4 mg ml
. Almost complete abolishment of growth was observed at 20 mg ml À1 . Fig. 2b shows the absorbance data from the CV assay that was performed on the biofilm. There was a modest reduction in biofilm biomass up to 5 mg ml
, followed by a precipitous decline between 5 and 10 mg ml À1 of PEA. Fig. 2c shows the bioluminescence data from the ATP assay that was performed to further characterize the biofilm. The lowest PEA concentration that yielded bioluminescence data that were different from those of the unsupplemented TSB with statistical significance was 1 mg ml
. ATP was almost abolished at 3 mg ml À1 of PEA.
To determine whether the effect of PEA on planktonic growth and biofilm amounts of AJW678 was due to PEA itself or one of its degradation products (phenylacetaldehyde or phenylacetic acid), the experiment was repeated, comparing AJW678 with its isogenic DtynA750 :: kan and DfeaB749 :: kan mutants (Fig. 3) . The effect of PEA on planktonic growth was almost identical for the three genetic strains (Fig. 3a) . For biofilm biomass, the feaB mutant strain formed slightly less biofilm than the genetic parent and the tynA mutant strain in the absence of PEA and at the two lowest PEA concentrations (Fig. 3b) . However, the effect of PEA on biofilm amounts was still comparable between the three strains. The effect of PEA on the ATP content of the biofilm was again very similar for all tested strains (Fig. 3c) .
In a second experiment, PEA was added to TSB in different concentrations and at different times during the biofilm development of AJW678 at 37 C. Error bars were omitted from the trend line data in Fig. 4 , but the results from the t-test are included in Table S2 . Fig. 4a shows that PEA reduced planktonic growth over the 24 h incubation period when added at any time. The IC 50 was only mildly affected by the time of addition (Table S2) ; adding PEA at later times yielded lower IC 50 values (2.1 mg ml À1 for the 12 h addition versus 3.45 mg ml À1 for the 0 h addition of PEA). In Fig. 3 . The AJW678 planktonic growth (a), biofilm biomass (b) and ATP content of biofilm (c) were compared to those for isogenic isolates with mutations in the PEA catabolism genes that had been grown for 24 h at 37 C under varying concentrations of PEA. The averages and standard errors were calculated across six replicates. Circles, AJW678; diamonds, DtynA750::kan; triangles, DfeaB749::kan.
contrast, the percentage reduction caused by PEA was larger for the early times of PEA addition than for the late ones (0 h, 93 %; 2 h, 81 %; 4 h, 62 %; 6 h, 60 %; 8 h, 54 %; 12 h, 27 %). Fig. 4b shows the bioluminescence data from the ATP assay on the biofilms. PEA reduced ATP when added at any time, albeit at much higher PEA concentrations than were needed to reduce planktonic growth. For all times of addition, we observed an increase in ATP first, which was followed by a precipitous decline around 20 mg ml
. This increase prevented us from computing the IC 50 values for three of the six times of PEA addition (Table S2 ). For any of the times of PEA addition, Student's t-test revealed that a statistically significant difference from the 0 mg ml À1 PEA samples could not be demonstrated until 10 or more mg ml À1 of PEA were added (Table S2 ).
Fig . 5 shows the planktonic growth and ATP contents of biofilms that were grown by five bacterial pathogens for 16 h in TSB at 37 C, while Table S3 lists the corresponding IC 50 values and results from the t-test. PEA was supplemented at the time of inoculation. PEA started to reduce planktonic growth for P. aeruginosa (circles, solid trend line) at a concentration of 0.25 mg ml À1 (Fig. 5a ) with an IC 50 value of 4.1 mg ml
. S. aureus (squares, solid trend line) planktonic growth declined steadily between 0 and 10 mg ml À1 of PEA and dropped drastically towards 20 mg ml
. The IC 50 was 22 mg ml C in TSB, the pathogens S. aureus and P. aeruginosa exhibited the highest levels of ATP in their biofilm. PEA started to reduce ATP for P. aeruginosa (circles, solid trend line) at a concentration of 0.05 mg ml À1 and the IC 50 was 3.2 mg ml À1 . For S. aureus (squares, solid trend line), PEA started to reduce ATP at 5 mg ml À1 and the IC 50 was 12 mg ml
. PEA reduced the ATP content for E. coli EDL932 (diamonds, solid trend line) in a continuous manner with an IC 50 value of 7.9 mg ml
. E. coli UMN026 (triangles, solid trend line) exhibited an increase in ATP that peaked at 3 mg ml À1 of PEA, followed by a rather drastic decrease towards 10 mg ml
. The IC 50 value was calculated at 5.2 mg ml À1 of PEA. E. coli CFT073 (triangles, dashed trend line) exhibited a continuous decrease in ATP with increasing concentrations of PEA with an IC 50 value of 6.3 mg ml À1 .
Flushes of PEA reduced the ATP content and viable bacteria of biofilm in silicone tubing.
To test one application of PEA, we developed a silicone tubing model, resembling an intravenous catheter with antibiotic-lock therapy. AJW678, the two uropathogenic E. coli strains, P. aeruginosa and S. aureus were grown in the tubings, which were flushed with PEA three times during the 2-week incubation period. Throughout the three experiments (Fig. 6 ), P. aeruginosa was the pathogen that formed the largest amount of biofilm in the absence of PEA. When the PEA treatment was used at a concentration of 100 mg ml À1 (Fig. 6a) , the ATP content of all bacteria was reduced drastically. The percentage reductions ranged from 98.5 % for E. coli CFT073 to 99.9 % for S. aureus (Table S4 ). Student's t-test calculated a statistically significant difference between the biofilm in the absence and presence of PEA for all five bacterial strains. When the PEA treatment was used at a concentration of 10 mg ml À1 (Fig. 6b) , the reductions of ATP were very similar to those for the 100 mg ml À1 flush. S. aureus exhibited the lowest percentage reduction at 96.3 %, while the remaining strains had percentage reductions of between 99.6 and 99.8 %. As for the 100 mg ml À1 PEA experiment, the result from Student's t-test implied a statistically significant difference between the biofilm in the absence and presence of PEA for all five bacterial strains. When the PEA treatment was used at a concentration of 1 mg ml À1 , the outcome changed (Fig. 6c) . The five strains still showed a minor reduction in the ATP content of their biofilm. Student's t-test only yielded a statistically significant difference between the biofilm in the absence and presence of PEA for E. coli CFT073. In summary, the PEA treatment reduced the ATP content of biofilm grown in silicone tubing when used at a concentration of at least 10 mg ml
.
The experiment was repeated with S. aureus and P. aeruginosa to determine the viable cells within the biofilm (Fig. 7 and Table S5 ). The biofilm biomass (CV assay) yielded a much smaller difference between the two treatments for S. aureus, but showed a 67 % reduction by PEA for P. aeruginosa (Fig. 7a) . Comparing the percentage reductions from the ATP assay (Fig. 7b) with those from the viable cell counts (Fig. 7c) , S. aureus exhibited a 99.5 % reduction by PEA for the ATP assay and a 69.3 % reduction for the viable cell counts. P. aeruginosa had a percentage reduction of 99.9 % in both assays. It is possible that the percentage reduction for S. aureus in the viable cell counts is an underestimate due to the low cell number in the untreated control and the fact that 999 c.f.u. ml À1 was the lower limit of detection for our assay. At this point, we do not know whether a reduction in the viable cell counts can serve as the sole explanation for the reduction in the ATP content of the biofilm for this bacterium. For P. aeruginosa, this may be the case.
DISCUSSION
In this study, we showed that PEA reduced planktonic growth, as well as the biomass and ATP content of the biofilm, for the non-pathogenic E. coli K-12 strain AJW678 and several bacterial pathogens that are relevant in clinical environments. For the E. coli K-12 strain, this was seen when PEA was added at the time of the inoculation of the bacterial culture or later during biofilm development. As a major finding of our study, PEA reduced the ATP content of the biofilm for all the bacterial strains tested and the viable cell counts of the biofilm for P. aeruginosa and S. aureus for biofilms that had formed inside of small pieces of silicone tubing, modelled after the antibiotic-lock treatment for intravenous catheters.
We used different parameters to characterize the biofilms (for a review on biofilm quantification methods, see [33] ). CV complexes with a wide range of negatively charged surface molecules, including those associated with live and dead bacteria, as well as the EPS matrix [34] . This assay has been used in many biofilm studies, including some by our own research laboratory [21, 35] . The data obtained from this assay were referred to as 'biofilm biomass' throughout this paper. Since the CV assay does not distinguish between live and dead bacteria, we used an ATP bioluminescence assay to quantify the metabolic activity of live cells. This assay relies on the conversion of luciferin and ATP to oxyluciferin and AMP by the enzyme luciferase with the concomitant emission of luminescence. The ATP content of bacteria does not vary with the growth rate [36] and has a linear correlation between the luminescence signal and the number of viable bacteria in planktonic culture [37] . However, the correlation between the ATP signal and viable bacteria is less clear in biofilm-bound bacteria compared to planktonic bacteria. Therefore, we have used the term 'ATP content' instead of 'viable bacteria' when referring to results from this assay. However, the viable cell determination ( Fig. 7) suggests that PEA does indeed reduce the number of viable bacteria within the biofilm.
In our first set of experiments (Figs 1-4) , we expanded upon the observation from the previous study that had identified PEA as a growth and biofilm inhibitor when supplied in liquid beef broth medium [20] . As a starting point towards testing a larger selection of bacterial strains for their response to PEA, we selected a non-pathogenic E. coli strain and five bacterial pathogens. PEA reduced planktonic growth and ATP content in the biofilms of all of the bacterial strains tested and under all of the tested conditions. However, the extent of these reductions was dependent upon the bacterial strain and the conditions under which these biofilms had been cultured. In particular, Fig. 6 . ATP content of biofilm grown in silicone tubing in the presence of 100 mg ml À1 (a), 10 mg ml À1 (b) and 1 mg ml À1 (c) of PEA. PEA was flushed through the tubing three times during the 2 weeks of incubation at 37 C, and the biofilm was characterized with the ATP assay at the end of the incubation. The circles represent the individual data points from the six replicates, and the averages and standard errors are in red. For each bacterial strain, the first set of data points (open circles) is from the 0 mg ml À1 of PEA control experiment, while the second set are the data points from the PEA treatment (closed circles). The asterisks above the data points indicate pathogens for which the ATP content of the biofilm grown in the presence of PEA showed a statistically significant difference from that of the biofilm that was obtained in the absence of PEA (Student's t-test). supplementing PEA to the bacterial growth media at later time points during biofilm development decreased the percentage reduction that could be accomplished by adding PEA to the bacterial growth medium. Our data are in agreement with the idea that PEA added at the beginning of the experiment may serve as a biofilm prevention technique, whereas PEA added later will act as a treatment of the biofilm.
In some of our experiments with E. coli (Fig. 4b, AJW678 ; Fig. 5b, E. coli UMN026) , we observed an increase in the ATP content of the biofilm at moderate PEA concentrations (~3 mg ml ), followed by a decline towards higher concentrations of PEA (>10 mg ml À1 ). We offer two possible explanations for this phenomenon. First, it is possible that the activities of the PEA degrading enzymes TynA and FeaB, which convert PEA to phenylacetaldehyde and phenylacetic acid [38] , enable E. coli to utilize PEA as a carbon source. In fact, aromatic amino acids and amines are thought to be major nutrient sources for E. coli living in the intestine (for a review, see [39] ). As a second possible explanation, sub-lethal concentrations of PEA might fail to inhibit and instead enhance biofilm formation. Similar results have been seen with P. aeruginosa, where sub-lethal doses of cefotaxim, amoxicillin and azithromycin enhanced biofilm formation in the presence of chlorohexidine [40] . In both possible scenarios, larger concentrations of PEA seemed to overcome the obstacle and high concentrations of PEA were clearly exhibiting an inhibitory effect on all parameters of bacterial growth that were tested. We would like to point out that any possible clinical application of PEA as a novel anti-microbial will require further experimentation to determine its efficacy under the desired conditions.
To add clinical relevance to our study, we designed an experiment that resembled antibiotic-lock treatment in an intravenous catheter. An intravenous catheter is a long, flexible tube that is usually made of polytetrafluoroethylene, polyurethane, or silicone that is surgically threaded into the jugular vein and guided into the superior vena cava. After the procedure, the patient becomes more vulnerable to contracting a CLABSI [41] . One strategy to reduce catheterrelated infections has been to use antibiotic-lock therapy, where high concentrations of antibiotic solutions are left to dwell in the catheter when the catheter is not in use [42, 43] . Traditional antibiotics such as vancomycin, cefazolin, ceftazidime, ciprofloxacin, gentamicin and ampicillin are typically used for antibiotic-lock treatment [44] . This kind of treatment was shown to be effective at reducing CLABSI in cancer patients, but no significant conclusions could be drawn due to differences in administration and dwell time [22] .
The bacteria for this study were selected for their relevance to CLABSI and other biofilm-associated bacterial infections. A recent report from the World Health Organization ranked carbapenem-resistant P. aeruginosa and Enterobacteriaceae 'critical risk' and methicillin-and vancomycinresistant S. aureus 'high risk' [45] . In a new report on the pathogen distribution among paediatric healthcare-associated infections to the National Healthcare Safety Network, S. aureus ranked first in overall incidences, second in the occurrence of CLABSI and twelfth for catheter-related urinary tract infections [46] . E. coli ranked first in urinary tract infections, third overall and fifth in CLABSI. P. aeruginosa ranked second for urinary tract infections and seventh overall and for CLABSI.
The most relevant pathogen for our intravenous catheter model is likely S. aureus, which has been associated with CLABSI for a long time [47, 48] and catheter-related urinary tract infections more recently [49] . This pathogen exhibited percentage reductions of 99.5 % for the ATP assay and 69.3 % for the viable cell counts in response to three flushes of 100 mg ml À1 PEA in our catheter model ( Fig. 7 and Table S5 ). The percentage reduction for P. aeruginosa caused by PEA was 99.9 % for both the ATP assay and the viable cell counts (Fig. 7) . For the uropathogenic E. coli strains, we only have data on the ATP content of the biofilm (Fig. 6) . The reductions for both these strains were larger than 99.5 % at 10 mg ml À1 of PEA.
At this point, one may ask the question whether PEA might actually pose a health concern for the patients. PEA is the decarboxylation product of phenylalanine and is found naturally in bacteria, fungi, plants, animals and the human brain [50] [51] [52] . It is found in trace amounts in chocolate as a result of the thermal processing of cocoa [53] [54] [55] . It is important to note that PEA has generally regarded as safe (GRAS) status and does not constitute a known health hazard to humans. In fact, PEA is degraded quickly in the human body due to the activity of monoamine oxidase [56] . Lastly, PEA is commercially available for mood enhancement and to aid weight loss. The recommended dose is 500 mg or more per day. At this point, there is no reason to believe that PEA would be a health risk to the patients and we truly believe that further developing PEA as an antimicrobial will lead to a range of applications, including an antibiotic-lock treatment for intravenous catheters.
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